Former Global Regulatory Chief Laurie Smaldone, MD, Tapped as PharmApprove President
Laurie Smaldone, MD has been named President of PharmApprove, a leading strategic regulatory communications firm that helps maximize outcomes during the most critical milestones of the development cycle for drugs, biologics, and devices in the US and abroad.
Dr. Smaldone, formerly Senior VP of Global Regulatory Science at Bristol-Myers Squibb, will lead PharmApprove's expert team of regulatory communications and product development specialists in expanding not only the company's services, but its geographical reach as well, said PharmApprove founder and CEO Pete Taft.
"Laurie ...









